1Maitland - van der Zee AH, de Boer A, Hubertus Leufkens GM. The interface between pharmacoepidemiology and pharmacogenetics. Eur J of Pharmacol, 2000, 410:121.
2Meyer UA. Pharmacogenetics and adverse drug reactions.Lancet, 2000, 356: 1667.
3Pirmohamed M, Park BK. Genetic susceptibility to adverse drug reactions. Trends in Pharmacological Sciences, 2001,22 (6): 298.
4What is SNPs? (http: //cmbi. bjmu. edu. cn/cmbidata/snp)
5Smith G, Smith RL. Pharmacogenetics. BMJ, 2000,320: 987.
6Gould Rothberg BE. Publication of the human genome SNP map is an early benchmark in efforts to increase the efficiency of drug development and improve the provision of medicine. Nature biotechnology , 2001, 19: 209211(http: //biotech. nature. com)
7Roses AD. Pharmacogenetics and thepractice of medicine.Nature, 2000, 405 (15): 857 (www. nature. com).
